KalVista Pharmaceuticals, Inc. — Revenue by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8564566b-0f1c-4159-b2cc-54d1f9b93b2e/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2023 | $50.0M | 2023-05-01 – 2024-04-30 | evidence 0000950170-24-133673 |
| FY 2019 | $12.7M | 2019-05-01 – 2020-04-30 | evidence 0001564590-20-031501 |
| FY 2018 | $16.1M | 2018-05-01 – 2019-04-30 | evidence 0001564590-19-025009 |
| FY 2017 | $8.4M | 2017-05-01 – 2018-04-30 | evidence 0001564590-19-025009 |
| FY 2016 | $1.5M | 2016-05-01 – 2017-04-30 | evidence 0001564590-19-025009 |
| FY 2015 | $2.1M | 2015-05-01 – 2016-04-30 | evidence 0001564590-18-017915 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
KalVista Pharmaceuticals, Inc. — all facts · Net Income · Operating Income